Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Target Price at $39.88
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target […]
More Stories
Judge Rules Virginia Redistricting Referendum Unconstitutional
By Jill McLaughlin A Virginia judge ruled on April 22 that the state’s redistricting referendum approved by voters a day earlier...
US Land Prices Climb 77 Percent Since Pandemic as Inventory Remains Low: Report
By Mary Prenon Land prices across the United States over the last decade seem to be following the path of...
German Airline Lufthansa to Cut 20,000 Flights to Save Jet Fuel
By Victoria Friedman German airline Lufthansa announced on April 21 that 20,000 short-haul flights would be canceled this summer due...
Duffy Seeking $10 Billion From Congress to Revamp Air Traffic Control System
By Aldgra Fredly U.S. Transportation Secretary Sean Duffy said on April 21 the department requires $10 billion in additional funding...
Iran Attacks 2 Container Ships After Trump Extends Ceasefire
By Tom Ozimek Iranian forces fired on two commercial vessels near the Strait of Hormuz on April 22, UK maritime...
Southern Poverty Law Center Charged With Fraud Over Payments to Informants in Extremist Groups
By Tom Gantert The Southern Poverty Law Center was indicted on federal fraud charges that accused it of illegally raising...